financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Guardian Metal Resources Names Jake Mather as Chief Financial Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Guardian Metal Resources Names Jake Mather as Chief Financial Officer
Mar 26, 2026 3:54 AM

06:26 AM EDT, 03/26/2026 (MT Newswires) -- Guardian Metal Resources ( GMTL ) said Thursday it appointed Jake Mather as chief financial officer, effective immediately,

Mather most recently served as vice president of business development at Chile's Ceibo.

Guardian Metal said Benjamin Hodges will step down as financial director and assume his role as a nonexecutive director.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioCryst Pharma Q3 operating profit up, raises FY ORLADEYO sales guidance 
BioCryst Pharma Q3 operating profit up, raises FY ORLADEYO sales guidance 
Nov 3, 2025
Overview * BioCryst Q3 operating profit increased 285% y-o-y, reflecting strong leverage * ORLADEYO Q3 revenue up 37% y-o-y, driven by strong patient demand * Company raises FY 2025 ORLADEYO revenue guidance Outlook * BioCryst raises FY 2025 ORLADEYO revenue guidance to $590-$600 mln * Company lowers FY 2025 non-GAAP operating expenses to $430-$440 mln * Company expects positive cash...
 TG Therapeutics Q3 revenue up on strong demand, raises 2025 forecast
TG Therapeutics Q3 revenue up on strong demand, raises 2025 forecast
Nov 3, 2025
Overview * TG Therapeutics Q3 2025 revenue was $161.7 mln, driven by BRIUMVI sales * Company raises 2025 global revenue target to $600 mln, BRIUMVI U.S. target to $585 mln * Completed $100 mln share repurchase, authorized additional $100 mln program Outlook * TG Therapeutics ( TGTX ) raises 2025 global revenue target to $600 mln * Company increases 2025...
 Karyopharm Therapeutics' Q3 net loss widens
Karyopharm Therapeutics' Q3 net loss widens
Nov 3, 2025
Overview * Karyopharm Q3 total revenue rises to $44 mln, driven by XPOVIO sales growth * Net loss for Q3 2025 was $33.1 mln, slightly higher than last year * Company reaffirms full-year 2025 revenue guidance of $140 mln to $155 mln Outlook * Karyopharm reaffirms 2025 total revenue guidance of $140 mln to $155 mln * Company expects 2025...
 Mobility tech firm ECARX turns profitable on higher shipment volumes in Q3 
Mobility tech firm ECARX turns profitable on higher shipment volumes in Q3 
Nov 3, 2025
Overview * ECARX ( ECX ) Q3 revenue grows 11% YoY to $219.9 mln, driven by higher shipment volumes * Company achieves first net profit of $0.9 mln, compared to a loss last year * Adjusted EBITDA reaches $8.3 mln, reflecting improved operational efficiency Outlook * ECARX ( ECX ) expects to maintain growth momentum into next quarter and beyond...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved